Jinque Luo

Hunan Provincial Key Laboratory Of The Research And Development Of Novel Pharmaceutical Preparations
Changsha, 410219, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Targeting PKM2 by (+)-homocrepidine A restrains glycolytic reprogramming and reshapes macrophage fate to alleviate acute lung injury.

Targeting PKM2 by (+)-homocrepidine A restrains glycolytic reprogramming and reshapes macrophage fate to alleviate acute lung injury.

Journal: Biochemical pharmacology

Published: July 12, 2026

Association between low-dose trimethoprim-sulfamethoxazole blood concentration and clinical outcomes in non-HIV patients with Pneumocystis jirovecii pneumonia: a retrospective cohort study.

Association between low-dose trimethoprim-sulfamethoxazole blood concentration and clinical outcomes in non-HIV patients with Pneumocystis jirovecii pneumonia: a retrospective cohort study.

Journal: BMC infectious diseases

Published: November 05, 2025

Targeting adipocyte differentiation with CRT0066101: activation of AMPK signaling in 3T3-L1 cells.

Targeting adipocyte differentiation with CRT0066101: activation of AMPK signaling in 3T3-L1 cells.

Journal: Frontiers in pharmacology

Published: June 12, 2025

Application of AI-assisted multi-advisor system combined with BOPPPS teaching model in clinical pharmacy education.

Application of AI-assisted multi-advisor system combined with BOPPPS teaching model in clinical pharmacy education.

Journal: BMC medical education

Published: December 27, 2024

5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation.

5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation.

Journal: Frontiers in pharmacology

Published: November 05, 2024

ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed ApoE-/- Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux.

ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed ApoE-/- Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: October 10, 2024

Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review).

Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review).

Journal: Molecular medicine reports

Published: June 25, 2024

MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD.

MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD.

Journal: BMC cardiovascular disorders

Published: May 02, 2024

Hepatic Sirt6 activation abrogates acute liver failure.

Hepatic Sirt6 activation abrogates acute liver failure.

Journal: Cell death & disease

Published: October 10, 2023

SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells.

SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells.

Journal: Inflammation

Published: June 13, 2023

SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.

SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.

Journal: Circulation research

Published: October 24, 2022

Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism.

Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism.

Journal: Frontiers in pharmacology

Published: February 14, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026